- ICH GCP
- EU-Register für klinische Studien
Neueste Versuche
EudraCT Number: 2006-003821-10 | Sponsor Protocol Number: ML20681 | Start Date: 2006-11-27 | |||||||||||
Sponsor Name: Roche Farma, S.A. | |||||||||||||
Full Title: Estudio aleatorizado, abierto y cruzado para evaluar la tolerabilidad del dispositivo de inyección sin aguja B2000 para la administración de enfuvirtida. | |||||||||||||
Medical condition: Infección por el VIH, no especificada | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004710-41 | Sponsor Protocol Number: AMLBFM0401 | Start Date: 2006-11-26 | |||||||||||
Sponsor Name: St. Anna Kinderkrebsforschung | |||||||||||||
Full Title: Multizentrische Therapieoptimierungsstudie AML-BFM 2004 zur Behandlung der akuten myeloischen Leukämien bei Kindern und Jugendlichen Multicentric therapy optimizing study AML-BFM 2004 for the trea... | |||||||||||||
Medical condition: For acute myeloic leukaemia in children and juveniles improvment of treatment with new medications should be investigated: 1. Cladribine: originally licenced for hairy cell leukamia has shown good ... | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002698-38 | Sponsor Protocol Number: ALS-03-05-P-301 | Start Date: 2006-11-24 | ||||||
Sponsor Name: Air Liquide Sante International | ||||||||
Full Title: STUDY OF THE EFFICACY AND SAFETY OF KALINOX® 170 BAR FOR THE PERFORMANCE OF CARE PROCEDURES IN CHILDREN WITH BURNS | ||||||||
Medical condition: Study of the efficacy and tolerance of Kalinox 170 bar for the performance of care procedures in children with burn. | ||||||||
|
||||||||
Population Age: Children, Under 18 | Gender: | |||||||
Trial protocol: BE (Ongoing) ES (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001557-29 | Sponsor Protocol Number: A2171035 | Start Date: 2006-11-24 | |||||||||||
Sponsor Name: Pfizer Inc. | |||||||||||||
Full Title: A 52-WEEK MULTICENTER, OPEN-LABEL, RANDOMIZED, PARALLEL, TWO - ARM STUDY COMPARING EXUBERA® (INHALED HUMAN INSULIN) VS. HUMALOG® (INSULIN LISPRO), BOTH IN COMBINATION WITH INSULIN GLARGINE IN SUBJE... | |||||||||||||
Medical condition: Type 1 Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) DE (Prematurely Ended) GB (Prematurely Ended) NL (Completed) IE (Prematurely Ended) AT (Prematurely Ended) FI (Prematurely Ended) FR (Completed) SE (Prematurely Ended) BE (Completed) PT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002576-18 | Sponsor Protocol Number: A4061027 | Start Date: 2006-11-24 | |||||||||||
Sponsor Name: Pfizer Ltd. | |||||||||||||
Full Title: A PHASE 2 STUDY OF THE ANTI-ANGIOGENESIS AGENT AG-013736 IN PATIENTS METASTATIC OR UNRESECTABLE LOCALLY-ADVANCED THYROID CANCER REFRACTORY TO, OR NOT SUITABLE CANDIDATES FOR 131I TREATMENT | |||||||||||||
Medical condition: Treatment of patients with 131I-refractory metastatic or unresectable locally-advanced papillary, follicular, or Hurthle-cell thyroid cancer who are also refractory to, or intolerant of, or have cl... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003935-56 | Sponsor Protocol Number: TMC-CAN-05-03 | Start Date: 2006-11-24 | |||||||||||
Sponsor Name: The Medicines Company | |||||||||||||
Full Title: A clinical trial comparing treatment with cangrelor (in combination with usual care) to usual care, in subjects who require percutaneous coronary intervention | |||||||||||||
Medical condition: Subjects with coronary atherosclerosis (excluding ST segment-elevation MI [STEMI]) who require PCI (with or without stent). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) ES (Ongoing) CZ (Prematurely Ended) LT (Completed) SK (Completed) DE (Prematurely Ended) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002464-26 | Sponsor Protocol Number: 2006/175 | Start Date: 2006-11-24 | |||||||||||
Sponsor Name: Vejle Sygehus | |||||||||||||
Full Title: EFFEKTEN AF VELCADE PÅ KNOGLEVÆVET VED MYELOMATOSE (KNOGLEMARVSKRÆFT). | |||||||||||||
Medical condition: Multiple myeloma in adults. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005049-12 | Sponsor Protocol Number: RN1002-0066 | Start Date: 2006-11-24 | |||||||||||
Sponsor Name: Renovo Ltd | |||||||||||||
Full Title: A Double Blind, Placebo Controlled Trial to Investigate the Efficacy of Zesteem in Accelerating the Healing of Split Thickness Skin Graft Donor Sites | |||||||||||||
Medical condition: Wound Healing | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) DE (Completed) GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004437-15 | Sponsor Protocol Number: ONC-2006-002 | Start Date: 2006-11-24 | |||||||||||
Sponsor Name: ISTITUTO CLINICO HUMANITAS | |||||||||||||
Full Title: FASE II PROSPECTIVE STUDY BAY-43-90006 IN ADVANCED, METASTATIC SOFT TISSUE SARCOMAS, AFTER ANTRACYCLINE-BASED THERAPY | |||||||||||||
Medical condition: Histologically documented, progressive, advanced or metastatic sarcoma after adjuvant and/or first line antracycline-based regimen | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004065-34 | Sponsor Protocol Number: TUD-COFI06-014 | Start Date: 2006-11-24 | ||||||
Sponsor Name: Technical University Dresden | ||||||||
Full Title: Open labeled, multicenter phase I / II study evaluating the dose escalation/ safety of Cetuximab and Oxaliplatin/ 5-FU/FA/ Irinotecan as first-line treatment of metastatic colorectal cancer | ||||||||
Medical condition: first-line treatment of metastatic colorectal cancer | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) | ||||||||
Trial results: (No results available) |